Diagnosis and Treatment > Signs and Symptoms
Search for other papers by Khaled Aljenaee in
Google Scholar
PubMed
Search for other papers by Sulaiman Ali in
Google Scholar
PubMed
Search for other papers by Seong Keat Cheah in
Google Scholar
PubMed
Search for other papers by Owen MacEneaney in
Google Scholar
PubMed
Search for other papers by Niall Mulligan in
Google Scholar
PubMed
Search for other papers by Neil Hickey in
Google Scholar
PubMed
Search for other papers by Tommy Kyaw Tun in
Google Scholar
PubMed
Search for other papers by Seamus Sreenan in
Google Scholar
PubMed
Search for other papers by John H McDermott in
Google Scholar
PubMed
Markedly elevated androgen levels can lead to clinical virilization in females. Clinical features of virilization in a female patient, in association with biochemical hyperandrogenism, should prompt a search for an androgen-producing tumor, especially of ovarian or adrenal origin. We herein report the case of a 60-year-old woman of Pakistani origin who presented with the incidental finding of male pattern baldness and hirsutism. Her serum testosterone level was markedly elevated at 21 nmol/L (normal range: 0.4–1.7 nmol/L), while her DHEAS level was normal, indicating a likely ovarian source of her elevated testosterone. Subsequently, a CT abdomen-pelvis was performed, which revealed a bulky right ovary, confirmed on MRI of the pelvis as an enlarged right ovary, measuring 2.9 × 2.2 cm transaxially. A laparoscopic bilateral salpingo-oophorectomy was performed, and histopathological examination and immunohistochemistry confirmed the diagnosis of a Leydig cell tumor, a rare tumor accounting for 0.1% of ovarian tumors. Surgical resection led to normalization of testosterone levels.
Learning points:
-
Hirsutism in postmenopausal women should trigger suspicion of androgen-secreting tumor
-
Extremely elevated testosterone level plus normal DHEAS level point toward ovarian source
-
Leydig cell tumor is extremely rare cause of hyperandrogenicity